Heron Therapeutics Inc vs iShares Core S&P 500 ETF — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while iShares Core S&P 500 ETF trades at $776.06. The key difference: iShares Core S&P 500 ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | IVV | |
|---|---|---|
Market Cap | $61.47M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $1.49 | $776.81 |
52-Week Low | $0.32 | $634.93 |
Enterprise Value | $168.21M | — |
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →IVV tracks the performance of the S&P 500 Index, offering low-cost exposure to 500 of the largest US companies. It is a cornerstone for long-term investors seeking broad growth in the US stock market.
Read more on IVV →